To understand the molecular mechanism underlying the LUESCC-NRSN2 axis in promoting ESCC progression, transcriptome analysis was performed in KYSE510 cells transfected with control siRNA or siRNA specifically targeting NRSN2. The gene discussed is NRSN2; the disease is esophageal squamous cell carcinoma.